Ikarian Capital’s Immunic IMUX Stock Holding History

Ikarian Capital’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$749K	Hold	67,466	–	–	0.11%	116
2025 Q4	$360K	Sell	67,466 -23,951	-26%	-$175K	0.05%	143
2025 Q3	$806K	Hold	91,417	–	–	0.16%	126
2025 Q2	$638K	Hold	91,417	–	–	0.21%	87
2025 Q1	$996K	Sell	91,417 -70,000	-43%	-$756K	0.32%	99
2024 Q4	$1.61M	Buy	161,417 +112,067	+227%	+$1.41M	0.46%	89
2024 Q3	$814K	Hold	49,350	–	–	0.25%	106
2024 Q2	$548K	Sell	49,350 -111,888	-69%	-$1.39M	0.17%	92
2024 Q1	$2.13M	Buy	+161,238	New	+$2.1M	0.58%	86
2023 Q4	–	Sell	-45,000	Closed	-$551K	–	163
2023 Q3	$662K	Sell	45,000 -20,000	-31%	-$384K	0.25%	105
2023 Q2	$1.63M	Hold	65,000	–	–	0.58%	73
2023 Q1	$969K	Hold	65,000	–	–	0.4%	82
2022 Q4	$910K	Buy	+65,000	New	+$1.77M	0.38%	52
2022 Q3	–	Sell	-6,150	Closed	-$214K	–	142
2022 Q2	$214K	Buy	+6,150	New	+$394K	0.09%	118
2022 Q1	–	Hold	0	–	–	–	212

Other funds holding IMUX

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return

683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return